Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcutis Biotherapeutics Inc. logo

Officer Matsuda Masaru sold $32,124 worth of shares (1,230 units at $26.12), decreasing direct ownership by 0.97% to 126,171 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARQT (Arcutis Biotherapeutics Inc.) and more on Quantisnow.